FEMS Microbiology Letters · 2004 · 141 citations · 20 references
Life SciencesMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryMycologyDrug-metabolizing EnzymesEnzyme InhibitionFungal BiochemistryFungal Secondary MetabolitesMetabolite IdentificationBioactive Fungal MetabolitesCancer Cell Line ModelsEndophytic Fungal MetabolitesFungal Bioactive CompoundsFungal Enzyme InhibitorsStructure Elucidation Of Fungal Metabolites
Fractionation of the extract of Aspergillus niger. IFB-E003, an endophyte in Cyndon dactylon, gave four known compounds naphtho-gamma-pyrones rubrofusarin B, fonsecinone A, asperpyrone B and aurasperone A, which were further investigated biologically. Rubrofusarin B was shown to be cytotoxic to the colon cancer cell line SW1116 (IC50: 4.5 microgml-1), and aurasperone A inhibitory on XO (xanthine oxidase) (IC50: 10.9 micromoll-1). Moreover, the four naphtho-gamma-pyrones exhibited growth inhibitions against the five test microbes with MICs ranging in between 1.9 and 31.2 microgml(-1). The present recognition of rubrofusarin B and aurasperone A as strong co-inhibitors on XO, colon cancer cell and some microbial pathogens is of significance for the imperative discovery of new relevant therapeutic agents.
20
Tsutomu Hatano, Hiroshi UEBAYASHI, Hideyuki Ito et al. · Chemical and Pharmaceutical Bulletin · 1999 · 197 citations · Full text